Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110


Cardiovascular outcomes of intravenous iron in perspective of clinical trials and the use of different iron preparations.

Toblli JE, Cao G, Angerosa M.

Int J Cardiol. 2015 May 6;187:196-7. doi: 10.1016/j.ijcard.2015.03.327. Epub 2015 Mar 21. No abstract available.


Role of angiotensin II and oxidative stress in renal inflammation by hypernatremia: Benefits of atrial natriuretic peptide, losartan, and tempol.

Della Penna SL, Rosón MI, Toblli JE, Fernández BE.

Free Radic Res. 2015 Apr;49(4):383-96. doi: 10.3109/10715762.2015.1006216. Epub 2015 Mar 6.


Changes in Echocardiographic Parameters in Iron Deficiency Patients with Heart Failure and Chronic Kidney Disease Treated with Intravenous Iron.

Toblli JE, Di Gennaro F, Rivas C.

Heart Lung Circ. 2015 Jan 21. pii: S1443-9506(15)00034-7. doi: 10.1016/j.hlc.2014.12.161. [Epub ahead of print]


Nitrosative stress and apoptosis in non-anemic healthy rats induced by intravenous iron sucrose similars versus iron sucrose originator.

Toblli JE, Cao G, Angerosa M.

Biometals. 2015 Apr;28(2):279-92. doi: 10.1007/s10534-015-9822-3. Epub 2015 Jan 22.


Optimizing iron delivery in the management of anemia: patient considerations and the role of ferric carboxymaltose.

Toblli JE, Angerosa M.

Drug Des Devel Ther. 2014 Dec 11;8:2475-91. doi: 10.2147/DDDT.S55499. eCollection 2014.


Thyrotropin-releasing hormone overexpression induces structural changes of the left ventricle in the normal rat heart.

Schuman ML, Peres Diaz LS, Landa MS, Toblli JE, Cao G, Alvarez AL, Finkielman S, Pirola CJ, García SI.

Am J Physiol Heart Circ Physiol. 2014 Dec 1;307(11):H1667-74. doi: 10.1152/ajpheart.00494.2014. Epub 2014 Oct 3.


Nitrosative Stress and Apoptosis by Intravenous Ferumoxytol, Iron Isomaltoside 1000, Iron Dextran, Iron Sucrose, and Ferric Carboxymaltose in a Nonclinical Model.

Toblli JE, Cao G, Giani JF, Dominici FP, Angerosa M.

Drug Res (Stuttg). 2014 Jul 22. [Epub ahead of print]


Renal angiotensin-converting enzyme is essential for the hypertension induced by nitric oxide synthesis inhibition.

Giani JF, Janjulia T, Kamat N, Seth DM, Blackwell WL, Shah KH, Shen XZ, Fuchs S, Delpire E, Toblli JE, Bernstein KE, McDonough AA, Gonzalez-Villalobos RA.

J Am Soc Nephrol. 2014 Dec;25(12):2752-63. doi: 10.1681/ASN.2013091030. Epub 2014 Jul 10.


Ferric carboxymaltose-mediated attenuation of Doxorubicin-induced cardiotoxicity in an iron deficiency rat model.

Toblli JE, Rivas C, Cao G, Giani JF, Funk F, Mizzen L, Dominici FP.

Chemother Res Pract. 2014;2014:570241. doi: 10.1155/2014/570241. Epub 2014 Apr 30.


Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.

Muñoz MC, Burghi V, Miquet JG, Giani JF, Banegas RD, Toblli JE, Fang Y, Wang F, Bartke A, Dominici FP.

J Endocrinol. 2014 Apr 22;221(2):215-27. doi: 10.1530/JOE-13-0497. Print 2014 May.


Renal overexpression of atrial natriuretic peptide and hypoxia inducible factor-1α as adaptive response to a high salt diet.

Della Penna SL, Cao G, Carranza A, Zotta E, Gorzalczany S, Cerrudo CS, Rukavina Mikusic NL, Correa A, Trida V, Toblli JE, Rosón MI, Fernández BE.

Biomed Res Int. 2014;2014:936978. doi: 10.1155/2014/936978. Epub 2014 Feb 13. Erratum in: Biomed Res Int. 2014;2014:718402.


Role of angiotensin II and oxidative stress on renal aquaporins expression in hypernatremic rats.

Della Penna SL, Cao G, Kouyoumdzian NM, Sarati L, Fellet A, Balaszczuk AM, Choi MR, Zotta E, Gorzalczany S, Pandolfo M, Toblli JE, Rosón MI, Fernández BE.

J Physiol Biochem. 2014 Jun;70(2):465-78. doi: 10.1007/s13105-014-0324-5. Epub 2014 Mar 4.


Nitric oxide and AQP2 in hypothyroid rats: a link between aging and water homeostasis.

Sarati LI, Toblli JE, Martinez CR, Uceda A, Feldman M, Balaszczuk AM, Fellet AL.

Metabolism. 2013 Sep;62(9):1287-95. doi: 10.1016/j.metabol.2013.04.013. Epub 2013 May 22.


Effects of iron polymaltose complex, ferrous fumarate and ferrous sulfate treatments in anemic pregnant rats, their fetuses and placentas.

Toblli JE, Cao G, Oliveri L, Angerosa M.

Inflamm Allergy Drug Targets. 2013 Jun;12(3):190-8.


Treatment of anemia with darbepoetin alfa in systolic heart failure.

Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ; RED-HF Committees; RED-HF Investigators.

N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10.


Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB; RED-HF Committees Investigators.

Eur J Heart Fail. 2013 Mar;15(3):334-41. doi: 10.1093/eurjhf/hfs204. Epub 2013 Jan 17.


Upregulation of the angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis in the heart and the kidney of growth hormone receptor knock-out mice.

Giani JF, Miquet JG, Muñoz MC, Burghi V, Toblli JE, Masternak MM, Kopchick JJ, Bartke A, Turyn D, Dominici FP.

Growth Horm IGF Res. 2012 Dec;22(6):224-33. doi: 10.1016/j.ghir.2012.08.003. Epub 2012 Sep 2.


Understanding the mechanisms of proteinuria: therapeutic implications.

Toblli JE, Bevione P, Di Gennaro F, Madalena L, Cao G, Angerosa M.

Int J Nephrol. 2012;2012:546039. doi: 10.1155/2012/546039. Epub 2012 Jul 4.


Salt-induced downregulation of renal aquaporins is prevented by losartan.

Della Penna SL, Cao G, Fellet A, Balaszczuk AM, Zotta E, Cerrudo C, Pandolfo M, Toblli JE, Fernández BE, Rosón MI.

Regul Pept. 2012 Aug 20;177(1-3):85-91. doi: 10.1016/j.regpep.2012.05.090. Epub 2012 May 12.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk